ACG-701 (formerly ARV-1801) is a version of sodium fusidate. It is a compound that is used to treat methicillin-resistant Staphylococcus aureus, a cause of some CF lung infections, and may also decrease inflammation and mucus production. Sodium fusidate has been used in Europe, but it has never been approved in the U.S. This potential treatment comes in oral tablet form.

Status

No further development in CF is planned at this time.

Sponsor

This program was sponsored by Aceragen and partially funded by the Cystic Fibrosis Foundation.